Pular para o conteúdo principal
Ranking Invest

ATRC - AtriCure, Inc.

Segmento: HealthcareAtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

Análise Ranking Invest

Valuation estimado
$ 443.82 Mi
Valor de Mercado
$ 2.78 Bi
Sobrepreço (AV)+525.5%
IVR
0.16A companhia vale 0,16 vezes o seu valor de mercado atual de acordo com a estimativa do Ranking Invest.
IVR2
-0.03O valuation alternativo equivale a -3% do valor de mercado da companhia.
MLL
-0.03O lucro líquido dos controladores em 16 trimestres equivale a -3% do valor de mercado.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

$ 516.43 Mi

Dívida Líquida

-$ 106.79 Mi

L4T

$ 10.55 Mi

MM4T

1.74%

Indicadores Básicos

ROE

2.04%

Índices de Previsibilidade

Receita Líquida

A0.02

Lucro

G12.47

Margem

E1.43

Índices de Tendência

Receita Líquida

A11.76

Lucro

B7.27

Margem

A8.51

Índices de Endividamento

DIV/PAT

-0.21

DIV/L4T

-10.12

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.